We then subjected the RAB4A-high PC3 prostate cancer and SNB19 glioblastoma cancer cells to stable RAB4A knockdown, which led to the observation that loss of RAB4A abolished cell invasion in both cell types (Fig. 5B and C). This evidence concerns the gene RAB4A and prostate cancer.